DF
CRL icon

Dunhill Financial’s Charles River Laboratories CRL Stock Holding History

Dunhill Financial’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$312 Sell
1
-1
-50% -$185 ﹤0.01% 1181
2025
Q4 		$493 Buy
2
+1
+100% +$181 ﹤0.01% 935
2025
Q3 		$175 Hold
1
– – ﹤0.01% 939
2025
Q2 		$267 Sell
1
-12
-92% -$1.6K ﹤0.01% 922
2025
Q1 		$1.97K Sell
13
-1
-7% -$168 ﹤0.01% 735
2024
Q4 		$2.59K Buy
14
+3
+27% +$578 ﹤0.01% 671
2024
Q3 		$2.23K Buy
11
+6
+120% +$1.25K ﹤0.01% 697
2024
Q2 		$1.11K Buy
5
+1
+25% +$227 ﹤0.01% 675
2024
Q1 		$1.16K Hold
4
– – ﹤0.01% 616
2023
Q4 		$856 Buy
+4
New +$787 ﹤0.01% 630

Other funds holding CRL

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $74.9B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return